Using an inducible KRIT1 endothelial‐specific knockout mouse that models CCM, we show that VEGFR2 activation plays a role in CCM pathogenesis, as inhibition of VEGFR2 kinase activity reduced the number of lesions formed. The gene discussed is KRIT1; the disease is cerebral cavernous malformation.